Spatiotemporal Analysis of RhoA/B/C Activation in Primary Human Endothelial Cells

Overview

Journal Sci Rep

Specialty Science

Date 2016 May 6

PMID 27147504

Citations 31

Authors

Nathalie R Reinhard

Suzanne F van Helden

Eloise C Anthony

Taofei Yin

Yi I Wu

Joachim Goedhart

Theodorus W J Gadella

Peter L Hordijk

Affiliations

Soon will be listed here.

Abstract

Endothelial cells line the vasculature and are important for the regulation of blood pressure, vascular permeability, clotting and transendothelial migration of leukocytes and tumor cells. A group of proteins that that control the endothelial barrier function are the RhoGTPases. This study focuses on three homologous (>88%) RhoGTPases: RhoA, RhoB, RhoC of which RhoB and RhoC have been poorly characterized. Using a RhoGTPase mRNA expression analysis we identified RhoC as the highest expressed in primary human endothelial cells. Based on an existing RhoA FRET sensor we developed new RhoB/C FRET sensors to characterize their spatiotemporal activation properties. We found all these RhoGTPase sensors to respond to physiologically relevant agonists (e.g. Thrombin), reaching transient, localized FRET ratio changes up to 200%. These RhoA/B/C FRET sensors show localized GEF and GAP activity and reveal spatial activation differences between RhoA/C and RhoB. Finally, we used these sensors to monitor GEF-specific differential activation of RhoA/B/C. In summary, this study adds high-contrast RhoB/C FRET sensors to the currently available FRET sensor toolkit and uncover new insights in endothelial and RhoGTPase cell biology. This allows us to study activation and signaling by these closely related RhoGTPases with high spatiotemporal resolution in primary human cells.

Citing Articles

Excitable Rho dynamics control cell shape and motility by sequentially activating ERM proteins and actomyosin contractility.

Marshall-Burghardt S, Migueles-Ramirez R, Lin Q, El Baba N, Saada R, Umar M Sci Adv. 2024; 10(36):eadn6858.

PMID: 39241071 PMC: 11378911. DOI: 10.1126/sciadv.adn6858.

Patterning of the cell cortex by Rho GTPases.

Bement W, Goryachev A, Miller A, von Dassow G Nat Rev Mol Cell Biol. 2024; 25(4):290-308.

PMID: 38172611 DOI: 10.1038/s41580-023-00682-z.

Opto-RhoGEFs, an optimized optogenetic toolbox to reversibly control Rho GTPase activity on a global to subcellular scale, enabling precise control over vascular endothelial barrier strength.

Mahlandt E, Palacios Martinez S, Arts J, Tol S, van Buul J, Goedhart J Elife. 2023; 12.

PMID: 37449837 PMC: 10393062. DOI: 10.7554/eLife.84364.

Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells.

Hauke M, Eckenstaler R, Ripperger A, Ender A, Braun H, Benndorf R J Am Heart Assoc. 2022; 11(12):e025119.

PMID: 35699166 PMC: 9238636. DOI: 10.1161/JAHA.121.025119.

A Thromboxane A Receptor-Driven COX-2-Dependent Feedback Loop That Affects Endothelial Homeostasis and Angiogenesis.

Eckenstaler R, Ripperger A, Hauke M, Petermann M, Hemkemeyer S, Schwedhelm E Arterioscler Thromb Vasc Biol. 2022; 42(4):444-461.

PMID: 35236104 PMC: 8939709. DOI: 10.1161/ATVBAHA.121.317380.

References

Bos J, Rehmann H, Wittinghofer A . GEFs and GAPs: critical elements in the control of small G proteins. Cell. 2007; 129(5):865-77. DOI: 10.1016/j.cell.2007.05.018. View

Ridley A . RhoA, RhoB and RhoC have different roles in cancer cell migration. J Microsc. 2013; 251(3):242-9. DOI: 10.1111/jmi.12025. View

Giannotta M, Trani M, Dejana E . VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell. 2013; 26(5):441-54. DOI: 10.1016/j.devcel.2013.08.020. View

Kroon J, Tol S, van Amstel S, Elias J, Fernandez-Borja M . The small GTPase RhoB regulates TNFα signaling in endothelial cells. PLoS One. 2013; 8(9):e75031. PMC: 3784429. DOI: 10.1371/journal.pone.0075031. View

Hutchinson C, Lowe P, McLaughlin S, Mott H, Owen D . Differential binding of RhoA, RhoB, and RhoC to protein kinase C-related kinase (PRK) isoforms PRK1, PRK2, and PRK3: PRKs have the highest affinity for RhoB. Biochemistry. 2013; 52(45):7999-8011. DOI: 10.1021/bi401216w. View

Zawistowski J, Sabouri-Ghomi M, Danuser G, Hahn K, Hodgson L . A RhoC biosensor reveals differences in the activation kinetics of RhoA and RhoC in migrating cells. PLoS One. 2013; 8(11):e79877. PMC: 3818223. DOI: 10.1371/journal.pone.0079877. View

Meiri D, Marshall C, Mokady D, Larose J, Mullin M, Gingras A . Mechanistic insight into GPCR-mediated activation of the microtubule-associated RhoA exchange factor GEF-H1. Nat Commun. 2014; 5:4857. DOI: 10.1038/ncomms5857. View

Abu Taha A, Schnittler H . Dynamics between actin and the VE-cadherin/catenin complex: novel aspects of the ARP2/3 complex in regulation of endothelial junctions. Cell Adh Migr. 2014; 8(2):125-35. PMC: 4049858. DOI: 10.4161/cam.28243. View

Marcos-Ramiro B, Garcia-Weber D, Millan J . TNF-induced endothelial barrier disruption: beyond actin and Rho. Thromb Haemost. 2014; 112(6):1088-102. DOI: 10.1160/TH14-04-0299. View

10.

Schaefer A, Reinhard N, Hordijk P . Toward understanding RhoGTPase specificity: structure, function and local activation. Small GTPases. 2014; 5(2):6. PMC: 4601309. DOI: 10.4161/21541248.2014.968004. View

11.

Vestweber D . Cadherins in tissue architecture and disease. J Mol Med (Berl). 2014; 93(1):5-11. DOI: 10.1007/s00109-014-1231-5. View

12.

Huveneers S, Daemen M, Hordijk P . Between Rho(k) and a hard place: the relation between vessel wall stiffness, endothelial contractility, and cardiovascular disease. Circ Res. 2015; 116(5):895-908. DOI: 10.1161/CIRCRESAHA.116.305720. View

13.

Lin B, Yin T, Wu Y, Inoue T, Levchenko A . Interplay between chemotaxis and contact inhibition of locomotion determines exploratory cell migration. Nat Commun. 2015; 6:6619. PMC: 4391292. DOI: 10.1038/ncomms7619. View

14.

Das S, Halushka M . Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol. 2015; 24(4):199-206. DOI: 10.1016/j.carpath.2015.04.007. View

15.

Yu O, Brown J . G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation. Mol Pharmacol. 2015; 88(1):171-80. PMC: 4468647. DOI: 10.1124/mol.115.097857. View

16.

Schaefer A, Hordijk P . Cell-stiffness-induced mechanosignaling - a key driver of leukocyte transendothelial migration. J Cell Sci. 2015; 128(13):2221-30. DOI: 10.1242/jcs.163055. View

17.

Korn C, Augustin H . Mechanisms of Vessel Pruning and Regression. Dev Cell. 2015; 34(1):5-17. DOI: 10.1016/j.devcel.2015.06.004. View

18.

Timmerman I, Heemskerk N, Kroon J, Schaefer A, van Rijssel J, Hoogenboezem M . A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1. J Cell Sci. 2015; 128(16):3041-54. DOI: 10.1242/jcs.168674. View

19.

van Hinsbergh V, Eringa E, Daemen M . Neovascularization of the atherosclerotic plaque: interplay between atherosclerotic lesion, adventitia-derived microvessels and perivascular fat. Curr Opin Lipidol. 2015; 26(5):405-11. DOI: 10.1097/MOL.0000000000000210. View

20.

Hoeppner L, Sinha S, Wang Y, Bhattacharya R, Dutta S, Gong X . RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells. J Cell Sci. 2015; 128(19):3556-68. PMC: 4647168. DOI: 10.1242/jcs.167601. View